The first selective Fatty Acid Binding Protein 5 inhibitor safely administered to human subjectsInitial safety and pharmacokinetic data expected ...

Korro Bio (KRRO) announced the initiation of dosing in its REWRITE study investigating KRRO-110 as a potential treatment for individuals with ...

Taiwan Coast Guard says ship that allegedly cut cable crewed by Chinese ...

OX640 is a nasal rescue medication with powder-based epinephrine for the treatment of allergic reactions (incl. anaphylaxis) and is based on the proprietary AmorphOX® technology.The clinical study, ...

Many of these drugs have shown promise in earlier studies for inhibiting viral replication or exhibit pharmacokinetic properties favorable for therapeutic application. By analyzing this set, we aimed ...

Hyderabad: Suven Life Sciences, a clinical stage biopharmaceutical company discovering and developing novel medicines to ...

PALO ALTO, CA and NEEDHAM, MA, USA and MELBOURNE, Australia I January 08, 2025 I Bitterroot Bio, a leader in developing innovative medicines in the field of ...

RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared delivery ...

Suven Life Sciences surged 9.51% to Rs 138.70 after the firm dosed first subjects in a Phase-1 clinical trial of SUVN-I6107 being conducted in USA under FDA acceptance of investigational new drug (IND ...

Advancement in Nanoparticle-Based NIRF Probes for Precision Visualization in Oncology. Open Access Library Journal, 12, 1-14. doi: 10.4236/oalib.1112471 . Molecular imaging has introduced new ...

A compound derived from Nectandra leucantha, a tree native to southern Brazil (local names: canela-seca or canela-branca), ...

In the MAD cohort, MBX 1416 appeared to increase GLP-1 within 60 minutes of a mixed meal tolerance test, suggesting a ...